nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—Doxorubicin—kidney cancer	0.286	1	CrCtD
Idarubicin—Anthracyclines—Doxorubicin—kidney cancer	0.233	0.657	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Doxorubicin—kidney cancer	0.122	0.343	CiPCiCtD
Idarubicin—Valrubicin—Doxorubicin—kidney cancer	0.0604	0.333	CrCrCtD
Idarubicin—Epirubicin—Doxorubicin—kidney cancer	0.0604	0.333	CrCrCtD
Idarubicin—Daunorubicin—Doxorubicin—kidney cancer	0.0604	0.333	CrCrCtD
Idarubicin—ABCC1—Dactinomycin—kidney cancer	0.0205	0.169	CbGbCtD
Idarubicin—ABCC1—Paclitaxel—kidney cancer	0.0146	0.12	CbGbCtD
Idarubicin—TOP2A—Doxorubicin—kidney cancer	0.0142	0.117	CbGbCtD
Idarubicin—ABCC1—Vinblastine—kidney cancer	0.0128	0.106	CbGbCtD
Idarubicin—ABCC1—Vincristine—kidney cancer	0.0126	0.104	CbGbCtD
Idarubicin—CYP2D6—Temsirolimus—kidney cancer	0.00968	0.0798	CbGbCtD
Idarubicin—ABCC1—Doxorubicin—kidney cancer	0.00787	0.0649	CbGbCtD
Idarubicin—CYP2C9—Capecitabine—kidney cancer	0.0058	0.0478	CbGbCtD
Idarubicin—CYP2D6—Pazopanib—kidney cancer	0.00508	0.0419	CbGbCtD
Idarubicin—CYP2C9—Paclitaxel—kidney cancer	0.00363	0.03	CbGbCtD
Idarubicin—CYP2D6—Erlotinib—kidney cancer	0.00363	0.0299	CbGbCtD
Idarubicin—CYP2C9—Sorafenib—kidney cancer	0.00323	0.0266	CbGbCtD
Idarubicin—CYP2D6—Sorafenib—kidney cancer	0.00295	0.0243	CbGbCtD
Idarubicin—CYP2D6—Vinblastine—kidney cancer	0.00291	0.024	CbGbCtD
Idarubicin—CYP2D6—Doxorubicin—kidney cancer	0.00179	0.0148	CbGbCtD
Idarubicin—Epirubicin—AURKA—kidney cancer	0.000646	0.534	CrCbGaD
Idarubicin—Doxorubicin—AURKA—kidney cancer	0.000371	0.307	CrCbGaD
Idarubicin—TOP2A—Docetaxel—Paclitaxel—kidney cancer	0.000231	0.235	CbGdCrCtD
Idarubicin—TOP2A—Vindesine—Vinblastine—kidney cancer	0.000117	0.12	CbGdCrCtD
Idarubicin—TOP2A—Vindesine—Vincristine—kidney cancer	0.000117	0.12	CbGdCrCtD
Idarubicin—TOP2A—Gefitinib—Erlotinib—kidney cancer	0.00011	0.113	CbGdCrCtD
Idarubicin—Daunorubicin—CYP1A1—kidney cancer	9.82e-05	0.0812	CrCbGaD
Idarubicin—TOP2A—Vinorelbine—Vincristine—kidney cancer	7.4e-05	0.0755	CbGdCrCtD
Idarubicin—TOP2A—Vinorelbine—Vinblastine—kidney cancer	7.4e-05	0.0755	CbGdCrCtD
Idarubicin—TOP2A—Vincristine—Vinblastine—kidney cancer	6.33e-05	0.0645	CbGdCrCtD
Idarubicin—Daunorubicin—ABCB1—kidney cancer	5.22e-05	0.0432	CrCbGaD
Idarubicin—TOP2A—Vinblastine—Vincristine—kidney cancer	5.09e-05	0.0519	CbGdCrCtD
Idarubicin—Doxorubicin—ABCB1—kidney cancer	4.24e-05	0.035	CrCbGaD
Idarubicin—TOP2A—Cytarabine—Gemcitabine—kidney cancer	4.16e-05	0.0424	CbGdCrCtD
Idarubicin—Anaphylactic shock—Sorafenib—kidney cancer	3.97e-05	0.000791	CcSEcCtD
Idarubicin—Acute coronary syndrome—Paclitaxel—kidney cancer	3.97e-05	0.00079	CcSEcCtD
Idarubicin—Leukopenia—Dactinomycin—kidney cancer	3.97e-05	0.00079	CcSEcCtD
Idarubicin—Diarrhoea—Pazopanib—kidney cancer	3.96e-05	0.000789	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	3.96e-05	0.000788	CcSEcCtD
Idarubicin—Myocardial infarction—Paclitaxel—kidney cancer	3.94e-05	0.000786	CcSEcCtD
Idarubicin—Infection—Sorafenib—kidney cancer	3.94e-05	0.000786	CcSEcCtD
Idarubicin—Atrioventricular block—Doxorubicin—kidney cancer	3.92e-05	0.000781	CcSEcCtD
Idarubicin—Stomatitis—Paclitaxel—kidney cancer	3.92e-05	0.000781	CcSEcCtD
Idarubicin—Angiopathy—Gemcitabine—kidney cancer	3.91e-05	0.00078	CcSEcCtD
Idarubicin—Vomiting—Temsirolimus—kidney cancer	3.91e-05	0.000779	CcSEcCtD
Idarubicin—Shock—Sorafenib—kidney cancer	3.91e-05	0.000778	CcSEcCtD
Idarubicin—Immune system disorder—Gemcitabine—kidney cancer	3.9e-05	0.000776	CcSEcCtD
Idarubicin—Thrombocytopenia—Sorafenib—kidney cancer	3.89e-05	0.000774	CcSEcCtD
Idarubicin—Rash—Temsirolimus—kidney cancer	3.88e-05	0.000772	CcSEcCtD
Idarubicin—Blood uric acid increased—Doxorubicin—kidney cancer	3.87e-05	0.000772	CcSEcCtD
Idarubicin—Dermatitis—Temsirolimus—kidney cancer	3.87e-05	0.000771	CcSEcCtD
Idarubicin—Chills—Gemcitabine—kidney cancer	3.87e-05	0.000771	CcSEcCtD
Idarubicin—Skin disorder—Sorafenib—kidney cancer	3.86e-05	0.000768	CcSEcCtD
Idarubicin—Arrhythmia—Gemcitabine—kidney cancer	3.85e-05	0.000768	CcSEcCtD
Idarubicin—Headache—Temsirolimus—kidney cancer	3.85e-05	0.000767	CcSEcCtD
Idarubicin—Decreased appetite—Erlotinib—kidney cancer	3.84e-05	0.000764	CcSEcCtD
Idarubicin—Alopecia—Gemcitabine—kidney cancer	3.81e-05	0.000759	CcSEcCtD
Idarubicin—Infection—Sunitinib—kidney cancer	3.8e-05	0.000756	CcSEcCtD
Idarubicin—Anorexia—Sorafenib—kidney cancer	3.78e-05	0.000754	CcSEcCtD
Idarubicin—Shock—Sunitinib—kidney cancer	3.76e-05	0.000749	CcSEcCtD
Idarubicin—Gastrointestinal pain—Vinblastine—kidney cancer	3.75e-05	0.000748	CcSEcCtD
Idarubicin—Thrombocytopenia—Sunitinib—kidney cancer	3.74e-05	0.000745	CcSEcCtD
Idarubicin—Gastrointestinal pain—Everolimus—kidney cancer	3.74e-05	0.000745	CcSEcCtD
Idarubicin—Skin disorder—Sunitinib—kidney cancer	3.71e-05	0.000739	CcSEcCtD
Idarubicin—Vomiting—Pazopanib—kidney cancer	3.68e-05	0.000734	CcSEcCtD
Idarubicin—Anaemia—Vincristine—kidney cancer	3.66e-05	0.000729	CcSEcCtD
Idarubicin—Colitis—Doxorubicin—kidney cancer	3.65e-05	0.000728	CcSEcCtD
Idarubicin—Rash—Pazopanib—kidney cancer	3.65e-05	0.000727	CcSEcCtD
Idarubicin—Nausea—Temsirolimus—kidney cancer	3.65e-05	0.000727	CcSEcCtD
Idarubicin—Dermatitis—Pazopanib—kidney cancer	3.65e-05	0.000727	CcSEcCtD
Idarubicin—Anorexia—Sunitinib—kidney cancer	3.64e-05	0.000725	CcSEcCtD
Idarubicin—Haemoglobin—Paclitaxel—kidney cancer	3.63e-05	0.000723	CcSEcCtD
Idarubicin—Abdominal pain—Vinblastine—kidney cancer	3.63e-05	0.000723	CcSEcCtD
Idarubicin—Headache—Pazopanib—kidney cancer	3.63e-05	0.000723	CcSEcCtD
Idarubicin—Abdominal pain—Everolimus—kidney cancer	3.62e-05	0.00072	CcSEcCtD
Idarubicin—Body temperature increased—Everolimus—kidney cancer	3.62e-05	0.00072	CcSEcCtD
Idarubicin—Haemorrhage—Paclitaxel—kidney cancer	3.61e-05	0.000719	CcSEcCtD
Idarubicin—Gastrointestinal pain—Erlotinib—kidney cancer	3.61e-05	0.000719	CcSEcCtD
Idarubicin—Infection—Dactinomycin—kidney cancer	3.59e-05	0.000716	CcSEcCtD
Idarubicin—TOP2A—Daunorubicin—Doxorubicin—kidney cancer	3.57e-05	0.0364	CbGdCrCtD
Idarubicin—TOP2A—Epirubicin—Doxorubicin—kidney cancer	3.57e-05	0.0364	CbGdCrCtD
Idarubicin—Urinary tract disorder—Paclitaxel—kidney cancer	3.57e-05	0.000711	CcSEcCtD
Idarubicin—Leukopenia—Vincristine—kidney cancer	3.54e-05	0.000706	CcSEcCtD
Idarubicin—Urethral disorder—Paclitaxel—kidney cancer	3.54e-05	0.000705	CcSEcCtD
Idarubicin—Thrombocytopenia—Dactinomycin—kidney cancer	3.54e-05	0.000705	CcSEcCtD
Idarubicin—Pancytopenia—Capecitabine—kidney cancer	3.52e-05	0.000701	CcSEcCtD
Idarubicin—Abdominal pain—Erlotinib—kidney cancer	3.49e-05	0.000695	CcSEcCtD
Idarubicin—Body temperature increased—Erlotinib—kidney cancer	3.49e-05	0.000695	CcSEcCtD
Idarubicin—Oesophagitis—Doxorubicin—kidney cancer	3.48e-05	0.000693	CcSEcCtD
Idarubicin—Anaemia—Gemcitabine—kidney cancer	3.47e-05	0.000691	CcSEcCtD
Idarubicin—Neutropenia—Capecitabine—kidney cancer	3.46e-05	0.00069	CcSEcCtD
Idarubicin—Decreased appetite—Sorafenib—kidney cancer	3.45e-05	0.000687	CcSEcCtD
Idarubicin—Anorexia—Dactinomycin—kidney cancer	3.45e-05	0.000687	CcSEcCtD
Idarubicin—Nausea—Pazopanib—kidney cancer	3.44e-05	0.000685	CcSEcCtD
Idarubicin—Neoplasm—Doxorubicin—kidney cancer	3.44e-05	0.000685	CcSEcCtD
Idarubicin—Convulsion—Vincristine—kidney cancer	3.43e-05	0.000683	CcSEcCtD
Idarubicin—Hypersensitivity—Vinblastine—kidney cancer	3.38e-05	0.000674	CcSEcCtD
Idarubicin—Hypersensitivity—Everolimus—kidney cancer	3.37e-05	0.000671	CcSEcCtD
Idarubicin—Leukopenia—Gemcitabine—kidney cancer	3.36e-05	0.00067	CcSEcCtD
Idarubicin—Flushing—Paclitaxel—kidney cancer	3.35e-05	0.000668	CcSEcCtD
Idarubicin—Decreased appetite—Sunitinib—kidney cancer	3.32e-05	0.000661	CcSEcCtD
Idarubicin—Sepsis—Doxorubicin—kidney cancer	3.3e-05	0.000658	CcSEcCtD
Idarubicin—Angiopathy—Paclitaxel—kidney cancer	3.28e-05	0.000653	CcSEcCtD
Idarubicin—Immune system disorder—Paclitaxel—kidney cancer	3.26e-05	0.00065	CcSEcCtD
Idarubicin—Acute coronary syndrome—Capecitabine—kidney cancer	3.26e-05	0.000648	CcSEcCtD
Idarubicin—Gastrointestinal pain—Sorafenib—kidney cancer	3.25e-05	0.000647	CcSEcCtD
Idarubicin—Chills—Paclitaxel—kidney cancer	3.24e-05	0.000646	CcSEcCtD
Idarubicin—Myocardial infarction—Capecitabine—kidney cancer	3.24e-05	0.000645	CcSEcCtD
Idarubicin—Anaphylactic shock—Vincristine—kidney cancer	3.23e-05	0.000644	CcSEcCtD
Idarubicin—Arrhythmia—Paclitaxel—kidney cancer	3.23e-05	0.000643	CcSEcCtD
Idarubicin—Stomatitis—Capecitabine—kidney cancer	3.22e-05	0.000641	CcSEcCtD
Idarubicin—Infection—Vincristine—kidney cancer	3.21e-05	0.000639	CcSEcCtD
Idarubicin—Phlebitis—Doxorubicin—kidney cancer	3.21e-05	0.000639	CcSEcCtD
Idarubicin—Chest pain—Gemcitabine—kidney cancer	3.2e-05	0.000637	CcSEcCtD
Idarubicin—Alopecia—Paclitaxel—kidney cancer	3.19e-05	0.000636	CcSEcCtD
Idarubicin—Thrombophlebitis—Doxorubicin—kidney cancer	3.19e-05	0.000636	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	3.18e-05	0.000632	CcSEcCtD
Idarubicin—Thrombocytopenia—Vincristine—kidney cancer	3.16e-05	0.00063	CcSEcCtD
Idarubicin—Hepatic function abnormal—Doxorubicin—kidney cancer	3.16e-05	0.000629	CcSEcCtD
Idarubicin—Urticaria—Sorafenib—kidney cancer	3.15e-05	0.000628	CcSEcCtD
Idarubicin—Malnutrition—Paclitaxel—kidney cancer	3.14e-05	0.000626	CcSEcCtD
Idarubicin—Decreased appetite—Dactinomycin—kidney cancer	3.14e-05	0.000626	CcSEcCtD
Idarubicin—Diarrhoea—Vinblastine—kidney cancer	3.14e-05	0.000626	CcSEcCtD
Idarubicin—Body temperature increased—Sorafenib—kidney cancer	3.14e-05	0.000625	CcSEcCtD
Idarubicin—Abdominal pain—Sorafenib—kidney cancer	3.14e-05	0.000625	CcSEcCtD
Idarubicin—Diarrhoea—Everolimus—kidney cancer	3.13e-05	0.000623	CcSEcCtD
Idarubicin—Gastrointestinal pain—Sunitinib—kidney cancer	3.12e-05	0.000622	CcSEcCtD
Idarubicin—Anorexia—Vincristine—kidney cancer	3.08e-05	0.000613	CcSEcCtD
Idarubicin—Anaphylactic shock—Gemcitabine—kidney cancer	3.07e-05	0.000611	CcSEcCtD
Idarubicin—Cardiac failure congestive—Doxorubicin—kidney cancer	3.05e-05	0.000607	CcSEcCtD
Idarubicin—Infection—Gemcitabine—kidney cancer	3.05e-05	0.000607	CcSEcCtD
Idarubicin—Body temperature increased—Sunitinib—kidney cancer	3.02e-05	0.000601	CcSEcCtD
Idarubicin—Abdominal pain—Sunitinib—kidney cancer	3.02e-05	0.000601	CcSEcCtD
Idarubicin—Diarrhoea—Erlotinib—kidney cancer	3.02e-05	0.000601	CcSEcCtD
Idarubicin—Thrombocytopenia—Gemcitabine—kidney cancer	3e-05	0.000598	CcSEcCtD
Idarubicin—TOP2A—Azacitidine—Gemcitabine—kidney cancer	2.98e-05	0.0304	CbGdCrCtD
Idarubicin—Haemoglobin—Capecitabine—kidney cancer	2.98e-05	0.000593	CcSEcCtD
Idarubicin—Skin disorder—Gemcitabine—kidney cancer	2.98e-05	0.000593	CcSEcCtD
Idarubicin—Haemorrhage—Capecitabine—kidney cancer	2.96e-05	0.00059	CcSEcCtD
Idarubicin—Gastrointestinal pain—Dactinomycin—kidney cancer	2.96e-05	0.000589	CcSEcCtD
Idarubicin—Hot flush—Doxorubicin—kidney cancer	2.95e-05	0.000588	CcSEcCtD
Idarubicin—Urinary tract disorder—Capecitabine—kidney cancer	2.93e-05	0.000583	CcSEcCtD
Idarubicin—Menopausal symptoms—Doxorubicin—kidney cancer	2.93e-05	0.000583	CcSEcCtD
Idarubicin—Hypersensitivity—Sorafenib—kidney cancer	2.92e-05	0.000583	CcSEcCtD
Idarubicin—Anorexia—Gemcitabine—kidney cancer	2.92e-05	0.000582	CcSEcCtD
Idarubicin—Vomiting—Vinblastine—kidney cancer	2.92e-05	0.000581	CcSEcCtD
Idarubicin—Vomiting—Everolimus—kidney cancer	2.91e-05	0.000579	CcSEcCtD
Idarubicin—Anaemia—Paclitaxel—kidney cancer	2.91e-05	0.000579	CcSEcCtD
Idarubicin—Urethral disorder—Capecitabine—kidney cancer	2.91e-05	0.000579	CcSEcCtD
Idarubicin—Rash—Everolimus—kidney cancer	2.88e-05	0.000574	CcSEcCtD
Idarubicin—Dermatitis—Everolimus—kidney cancer	2.88e-05	0.000574	CcSEcCtD
Idarubicin—Headache—Vinblastine—kidney cancer	2.88e-05	0.000573	CcSEcCtD
Idarubicin—Headache—Everolimus—kidney cancer	2.87e-05	0.000571	CcSEcCtD
Idarubicin—Body temperature increased—Dactinomycin—kidney cancer	2.86e-05	0.000569	CcSEcCtD
Idarubicin—Abdominal pain—Dactinomycin—kidney cancer	2.86e-05	0.000569	CcSEcCtD
Idarubicin—Leukopenia—Paclitaxel—kidney cancer	2.81e-05	0.000561	CcSEcCtD
Idarubicin—Hypersensitivity—Sunitinib—kidney cancer	2.81e-05	0.000561	CcSEcCtD
Idarubicin—Decreased appetite—Vincristine—kidney cancer	2.81e-05	0.000559	CcSEcCtD
Idarubicin—Vomiting—Erlotinib—kidney cancer	2.81e-05	0.000559	CcSEcCtD
Idarubicin—Rash—Erlotinib—kidney cancer	2.78e-05	0.000554	CcSEcCtD
Idarubicin—Dermatitis—Erlotinib—kidney cancer	2.78e-05	0.000554	CcSEcCtD
Idarubicin—Headache—Erlotinib—kidney cancer	2.76e-05	0.000551	CcSEcCtD
Idarubicin—Flushing—Capecitabine—kidney cancer	2.75e-05	0.000548	CcSEcCtD
Idarubicin—Nausea—Vinblastine—kidney cancer	2.73e-05	0.000543	CcSEcCtD
Idarubicin—Convulsion—Paclitaxel—kidney cancer	2.72e-05	0.000543	CcSEcCtD
Idarubicin—Nausea—Everolimus—kidney cancer	2.72e-05	0.000541	CcSEcCtD
Idarubicin—Diarrhoea—Sorafenib—kidney cancer	2.72e-05	0.000541	CcSEcCtD
Idarubicin—Angiopathy—Capecitabine—kidney cancer	2.69e-05	0.000536	CcSEcCtD
Idarubicin—Immune system disorder—Capecitabine—kidney cancer	2.68e-05	0.000533	CcSEcCtD
Idarubicin—Chest pain—Paclitaxel—kidney cancer	2.68e-05	0.000533	CcSEcCtD
Idarubicin—Decreased appetite—Gemcitabine—kidney cancer	2.66e-05	0.000531	CcSEcCtD
Idarubicin—Hypersensitivity—Dactinomycin—kidney cancer	2.66e-05	0.000531	CcSEcCtD
Idarubicin—Chills—Capecitabine—kidney cancer	2.66e-05	0.00053	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	2.66e-05	0.00053	CcSEcCtD
Idarubicin—Arrhythmia—Capecitabine—kidney cancer	2.65e-05	0.000527	CcSEcCtD
Idarubicin—Gastrointestinal pain—Vincristine—kidney cancer	2.64e-05	0.000526	CcSEcCtD
Idarubicin—Nausea—Erlotinib—kidney cancer	2.62e-05	0.000522	CcSEcCtD
Idarubicin—Alopecia—Capecitabine—kidney cancer	2.62e-05	0.000522	CcSEcCtD
Idarubicin—Diarrhoea—Sunitinib—kidney cancer	2.61e-05	0.000521	CcSEcCtD
Idarubicin—Malnutrition—Capecitabine—kidney cancer	2.58e-05	0.000514	CcSEcCtD
Idarubicin—Dehydration—Doxorubicin—kidney cancer	2.57e-05	0.000512	CcSEcCtD
Idarubicin—Anaphylactic shock—Paclitaxel—kidney cancer	2.57e-05	0.000511	CcSEcCtD
Idarubicin—Abdominal pain—Vincristine—kidney cancer	2.55e-05	0.000509	CcSEcCtD
Idarubicin—Body temperature increased—Vincristine—kidney cancer	2.55e-05	0.000509	CcSEcCtD
Idarubicin—Infection—Paclitaxel—kidney cancer	2.55e-05	0.000508	CcSEcCtD
Idarubicin—Shock—Paclitaxel—kidney cancer	2.52e-05	0.000503	CcSEcCtD
Idarubicin—Vomiting—Sorafenib—kidney cancer	2.52e-05	0.000503	CcSEcCtD
Idarubicin—Thrombocytopenia—Paclitaxel—kidney cancer	2.51e-05	0.0005	CcSEcCtD
Idarubicin—Rash—Sorafenib—kidney cancer	2.5e-05	0.000499	CcSEcCtD
Idarubicin—Dermatitis—Sorafenib—kidney cancer	2.5e-05	0.000498	CcSEcCtD
Idarubicin—Skin disorder—Paclitaxel—kidney cancer	2.49e-05	0.000496	CcSEcCtD
Idarubicin—Headache—Sorafenib—kidney cancer	2.49e-05	0.000495	CcSEcCtD
Idarubicin—Diarrhoea—Dactinomycin—kidney cancer	2.47e-05	0.000493	CcSEcCtD
Idarubicin—Anorexia—Paclitaxel—kidney cancer	2.45e-05	0.000487	CcSEcCtD
Idarubicin—Vomiting—Sunitinib—kidney cancer	2.43e-05	0.000484	CcSEcCtD
Idarubicin—Body temperature increased—Gemcitabine—kidney cancer	2.42e-05	0.000483	CcSEcCtD
Idarubicin—Rash—Sunitinib—kidney cancer	2.41e-05	0.00048	CcSEcCtD
Idarubicin—Dermatitis—Sunitinib—kidney cancer	2.41e-05	0.000479	CcSEcCtD
Idarubicin—Headache—Sunitinib—kidney cancer	2.39e-05	0.000477	CcSEcCtD
Idarubicin—Anaemia—Capecitabine—kidney cancer	2.39e-05	0.000475	CcSEcCtD
Idarubicin—Hypersensitivity—Vincristine—kidney cancer	2.38e-05	0.000474	CcSEcCtD
Idarubicin—Nausea—Sorafenib—kidney cancer	2.36e-05	0.00047	CcSEcCtD
Idarubicin—Leukopenia—Capecitabine—kidney cancer	2.31e-05	0.00046	CcSEcCtD
Idarubicin—Vomiting—Dactinomycin—kidney cancer	2.3e-05	0.000458	CcSEcCtD
Idarubicin—Rash—Dactinomycin—kidney cancer	2.28e-05	0.000454	CcSEcCtD
Idarubicin—Nausea—Sunitinib—kidney cancer	2.27e-05	0.000452	CcSEcCtD
Idarubicin—Pancytopenia—Doxorubicin—kidney cancer	2.27e-05	0.000452	CcSEcCtD
Idarubicin—Neutropenia—Doxorubicin—kidney cancer	2.23e-05	0.000445	CcSEcCtD
Idarubicin—Decreased appetite—Paclitaxel—kidney cancer	2.23e-05	0.000444	CcSEcCtD
Idarubicin—Diarrhoea—Vincristine—kidney cancer	2.21e-05	0.00044	CcSEcCtD
Idarubicin—Chest pain—Capecitabine—kidney cancer	2.2e-05	0.000438	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	2.18e-05	0.000435	CcSEcCtD
Idarubicin—Nausea—Dactinomycin—kidney cancer	2.15e-05	0.000428	CcSEcCtD
Idarubicin—Gastrointestinal pain—Paclitaxel—kidney cancer	2.1e-05	0.000418	CcSEcCtD
Idarubicin—Diarrhoea—Gemcitabine—kidney cancer	2.1e-05	0.000418	CcSEcCtD
Idarubicin—Infection—Capecitabine—kidney cancer	2.09e-05	0.000417	CcSEcCtD
Idarubicin—Stomatitis—Doxorubicin—kidney cancer	2.07e-05	0.000413	CcSEcCtD
Idarubicin—Shock—Capecitabine—kidney cancer	2.07e-05	0.000413	CcSEcCtD
Idarubicin—Thrombocytopenia—Capecitabine—kidney cancer	2.06e-05	0.000411	CcSEcCtD
Idarubicin—Vomiting—Vincristine—kidney cancer	2.05e-05	0.000409	CcSEcCtD
Idarubicin—Skin disorder—Capecitabine—kidney cancer	2.05e-05	0.000407	CcSEcCtD
Idarubicin—Urticaria—Paclitaxel—kidney cancer	2.04e-05	0.000406	CcSEcCtD
Idarubicin—Rash—Vincristine—kidney cancer	2.04e-05	0.000406	CcSEcCtD
Idarubicin—Dermatitis—Vincristine—kidney cancer	2.04e-05	0.000405	CcSEcCtD
Idarubicin—Abdominal pain—Paclitaxel—kidney cancer	2.03e-05	0.000404	CcSEcCtD
Idarubicin—Body temperature increased—Paclitaxel—kidney cancer	2.03e-05	0.000404	CcSEcCtD
Idarubicin—Headache—Vincristine—kidney cancer	2.02e-05	0.000403	CcSEcCtD
Idarubicin—Anorexia—Capecitabine—kidney cancer	2.01e-05	0.0004	CcSEcCtD
Idarubicin—Vomiting—Gemcitabine—kidney cancer	1.95e-05	0.000388	CcSEcCtD
Idarubicin—Rash—Gemcitabine—kidney cancer	1.93e-05	0.000385	CcSEcCtD
Idarubicin—Dermatitis—Gemcitabine—kidney cancer	1.93e-05	0.000385	CcSEcCtD
Idarubicin—Haemoglobin—Doxorubicin—kidney cancer	1.92e-05	0.000383	CcSEcCtD
Idarubicin—Headache—Gemcitabine—kidney cancer	1.92e-05	0.000382	CcSEcCtD
Idarubicin—Nausea—Vincristine—kidney cancer	1.92e-05	0.000382	CcSEcCtD
Idarubicin—Haemorrhage—Doxorubicin—kidney cancer	1.91e-05	0.000381	CcSEcCtD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	1.91e-05	0.00418	CbGpPWpGaD
Idarubicin—Hypersensitivity—Paclitaxel—kidney cancer	1.89e-05	0.000377	CcSEcCtD
Idarubicin—Urinary tract disorder—Doxorubicin—kidney cancer	1.89e-05	0.000376	CcSEcCtD
Idarubicin—Urethral disorder—Doxorubicin—kidney cancer	1.87e-05	0.000373	CcSEcCtD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—kidney cancer	1.85e-05	0.00406	CbGpPWpGaD
Idarubicin—Decreased appetite—Capecitabine—kidney cancer	1.83e-05	0.000365	CcSEcCtD
Idarubicin—Nausea—Gemcitabine—kidney cancer	1.82e-05	0.000363	CcSEcCtD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	1.81e-05	0.00396	CbGpPWpGaD
Idarubicin—Flushing—Doxorubicin—kidney cancer	1.77e-05	0.000353	CcSEcCtD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—kidney cancer	1.77e-05	0.00388	CbGpPWpGaD
Idarubicin—Diarrhoea—Paclitaxel—kidney cancer	1.76e-05	0.00035	CcSEcCtD
Idarubicin—Angiopathy—Doxorubicin—kidney cancer	1.73e-05	0.000345	CcSEcCtD
Idarubicin—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	1.73e-05	0.00379	CbGpPWpGaD
Idarubicin—Immune system disorder—Doxorubicin—kidney cancer	1.73e-05	0.000344	CcSEcCtD
Idarubicin—Gastrointestinal pain—Capecitabine—kidney cancer	1.72e-05	0.000343	CcSEcCtD
Idarubicin—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	1.72e-05	0.00376	CbGpPWpGaD
Idarubicin—Chills—Doxorubicin—kidney cancer	1.71e-05	0.000341	CcSEcCtD
Idarubicin—Arrhythmia—Doxorubicin—kidney cancer	1.71e-05	0.00034	CcSEcCtD
Idarubicin—Alopecia—Doxorubicin—kidney cancer	1.69e-05	0.000336	CcSEcCtD
Idarubicin—Urticaria—Capecitabine—kidney cancer	1.67e-05	0.000333	CcSEcCtD
Idarubicin—CYP2D6—Biological oxidations—ALDH1A1—kidney cancer	1.67e-05	0.00366	CbGpPWpGaD
Idarubicin—Body temperature increased—Capecitabine—kidney cancer	1.66e-05	0.000332	CcSEcCtD
Idarubicin—Abdominal pain—Capecitabine—kidney cancer	1.66e-05	0.000332	CcSEcCtD
Idarubicin—Malnutrition—Doxorubicin—kidney cancer	1.66e-05	0.000331	CcSEcCtD
Idarubicin—CYP2C9—Biological oxidations—ALDH1A1—kidney cancer	1.65e-05	0.00363	CbGpPWpGaD
Idarubicin—Vomiting—Paclitaxel—kidney cancer	1.63e-05	0.000325	CcSEcCtD
Idarubicin—Rash—Paclitaxel—kidney cancer	1.62e-05	0.000322	CcSEcCtD
Idarubicin—Dermatitis—Paclitaxel—kidney cancer	1.62e-05	0.000322	CcSEcCtD
Idarubicin—Headache—Paclitaxel—kidney cancer	1.61e-05	0.00032	CcSEcCtD
Idarubicin—CYP2C9—Arachidonic acid metabolism—CYP1A1—kidney cancer	1.58e-05	0.00346	CbGpPWpGaD
Idarubicin—Hypersensitivity—Capecitabine—kidney cancer	1.55e-05	0.000309	CcSEcCtD
Idarubicin—Anaemia—Doxorubicin—kidney cancer	1.54e-05	0.000306	CcSEcCtD
Idarubicin—Nausea—Paclitaxel—kidney cancer	1.52e-05	0.000304	CcSEcCtD
Idarubicin—Leukopenia—Doxorubicin—kidney cancer	1.49e-05	0.000297	CcSEcCtD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—kidney cancer	1.47e-05	0.00323	CbGpPWpGaD
Idarubicin—Convulsion—Doxorubicin—kidney cancer	1.44e-05	0.000287	CcSEcCtD
Idarubicin—Diarrhoea—Capecitabine—kidney cancer	1.44e-05	0.000287	CcSEcCtD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—kidney cancer	1.42e-05	0.00311	CbGpPWpGaD
Idarubicin—Chest pain—Doxorubicin—kidney cancer	1.42e-05	0.000282	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	1.41e-05	0.00028	CcSEcCtD
Idarubicin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	1.38e-05	0.00301	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	1.37e-05	0.00301	CbGpPWpGaD
Idarubicin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	1.36e-05	0.00299	CbGpPWpGaD
Idarubicin—Anaphylactic shock—Doxorubicin—kidney cancer	1.36e-05	0.00027	CcSEcCtD
Idarubicin—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	1.36e-05	0.00297	CbGpPWpGaD
Idarubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—kidney cancer	1.36e-05	0.00297	CbGpPWpGaD
Idarubicin—Infection—Doxorubicin—kidney cancer	1.35e-05	0.000269	CcSEcCtD
Idarubicin—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	1.35e-05	0.00295	CbGpPWpGaD
Idarubicin—Vomiting—Capecitabine—kidney cancer	1.34e-05	0.000267	CcSEcCtD
Idarubicin—Shock—Doxorubicin—kidney cancer	1.34e-05	0.000266	CcSEcCtD
Idarubicin—Thrombocytopenia—Doxorubicin—kidney cancer	1.33e-05	0.000265	CcSEcCtD
Idarubicin—Rash—Capecitabine—kidney cancer	1.33e-05	0.000264	CcSEcCtD
Idarubicin—Dermatitis—Capecitabine—kidney cancer	1.33e-05	0.000264	CcSEcCtD
Idarubicin—Headache—Capecitabine—kidney cancer	1.32e-05	0.000263	CcSEcCtD
Idarubicin—Skin disorder—Doxorubicin—kidney cancer	1.32e-05	0.000263	CcSEcCtD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—kidney cancer	1.3e-05	0.00286	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	1.3e-05	0.00286	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—ANXA2—kidney cancer	1.3e-05	0.00286	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—ATP7B—kidney cancer	1.3e-05	0.00286	CbGpPWpGaD
Idarubicin—Anorexia—Doxorubicin—kidney cancer	1.29e-05	0.000258	CcSEcCtD
Idarubicin—TOP2A—Cell Cycle, Mitotic—PSMD7—kidney cancer	1.29e-05	0.00283	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—AURKA—kidney cancer	1.26e-05	0.00276	CbGpPWpGaD
Idarubicin—Nausea—Capecitabine—kidney cancer	1.25e-05	0.000249	CcSEcCtD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CCND1—kidney cancer	1.24e-05	0.00273	CbGpPWpGaD
Idarubicin—Decreased appetite—Doxorubicin—kidney cancer	1.18e-05	0.000235	CcSEcCtD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—kidney cancer	1.17e-05	0.00255	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ACY1—kidney cancer	1.16e-05	0.00255	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—PSMD7—kidney cancer	1.16e-05	0.00253	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—AURKA—kidney cancer	1.12e-05	0.00246	CbGpPWpGaD
Idarubicin—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	1.11e-05	0.00244	CbGpPWpGaD
Idarubicin—Gastrointestinal pain—Doxorubicin—kidney cancer	1.11e-05	0.000221	CcSEcCtD
Idarubicin—ABCC1—Disease—CCBL1—kidney cancer	1.11e-05	0.00243	CbGpPWpGaD
Idarubicin—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	1.11e-05	0.00242	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	1.08e-05	0.00236	CbGpPWpGaD
Idarubicin—Urticaria—Doxorubicin—kidney cancer	1.08e-05	0.000215	CcSEcCtD
Idarubicin—Abdominal pain—Doxorubicin—kidney cancer	1.07e-05	0.000214	CcSEcCtD
Idarubicin—Body temperature increased—Doxorubicin—kidney cancer	1.07e-05	0.000214	CcSEcCtD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	1.07e-05	0.00234	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.04e-05	0.00229	CbGpPWpGaD
Idarubicin—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	1.03e-05	0.00225	CbGpPWpGaD
Idarubicin—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	1.02e-05	0.00223	CbGpPWpGaD
Idarubicin—ABCC1—Disease—AMER1—kidney cancer	1e-05	0.0022	CbGpPWpGaD
Idarubicin—Hypersensitivity—Doxorubicin—kidney cancer	1e-05	0.000199	CcSEcCtD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—MYC—kidney cancer	9.99e-06	0.00219	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	9.91e-06	0.00217	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	9.89e-06	0.00217	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PDHB—kidney cancer	9.88e-06	0.00217	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—GSTT1—kidney cancer	9.81e-06	0.00215	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—GSTT1—kidney cancer	9.72e-06	0.00213	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDKN2B—kidney cancer	9.45e-06	0.00207	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	9.43e-06	0.00207	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	9.41e-06	0.00206	CbGpPWpGaD
Idarubicin—CYP2C9—Arachidonic acid metabolism—PTGS2—kidney cancer	9.38e-06	0.00206	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	9.34e-06	0.00205	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CCBL1—kidney cancer	9.29e-06	0.00204	CbGpPWpGaD
Idarubicin—Diarrhoea—Doxorubicin—kidney cancer	9.29e-06	0.000185	CcSEcCtD
Idarubicin—CYP2D6—Biological oxidations—PTGS1—kidney cancer	9.19e-06	0.00201	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—PTGS1—kidney cancer	9.11e-06	0.002	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	9.1e-06	0.00199	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—JUN—kidney cancer	9.03e-06	0.00198	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—PTEN—kidney cancer	8.74e-06	0.00191	CbGpPWpGaD
Idarubicin—Vomiting—Doxorubicin—kidney cancer	8.63e-06	0.000172	CcSEcCtD
Idarubicin—Rash—Doxorubicin—kidney cancer	8.56e-06	0.00017	CcSEcCtD
Idarubicin—Dermatitis—Doxorubicin—kidney cancer	8.55e-06	0.00017	CcSEcCtD
Idarubicin—TOP2A—Cell Cycle—BRCA2—kidney cancer	8.52e-06	0.00187	CbGpPWpGaD
Idarubicin—Headache—Doxorubicin—kidney cancer	8.5e-06	0.000169	CcSEcCtD
Idarubicin—TOP2A—Cell Cycle—CDKN2B—kidney cancer	8.45e-06	0.00185	CbGpPWpGaD
Idarubicin—ABCC1—Disease—GPC3—kidney cancer	8.41e-06	0.00184	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	8.4e-06	0.00184	CbGpPWpGaD
Idarubicin—CYP2D6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	8.31e-06	0.00182	CbGpPWpGaD
Idarubicin—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	8.24e-06	0.00181	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	8.22e-06	0.0018	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—BIRC5—kidney cancer	8.15e-06	0.00179	CbGpPWpGaD
Idarubicin—Nausea—Doxorubicin—kidney cancer	8.06e-06	0.000161	CcSEcCtD
Idarubicin—ABCC1—Metabolism—PPAT—kidney cancer	8.05e-06	0.00176	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GLIPR1—kidney cancer	8.05e-06	0.00176	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	8.04e-06	0.00176	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	7.95e-06	0.00174	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	7.87e-06	0.00173	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ST3GAL2—kidney cancer	7.78e-06	0.0017	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	7.78e-06	0.0017	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	7.56e-06	0.00166	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—FH—kidney cancer	7.49e-06	0.00164	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—APRT—kidney cancer	7.49e-06	0.00164	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	7.4e-06	0.00162	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	7.32e-06	0.0016	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—BIRC5—kidney cancer	7.29e-06	0.0016	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PGK1—kidney cancer	7.29e-06	0.0016	CbGpPWpGaD
Idarubicin—ABCC1—Disease—SLC5A3—kidney cancer	7.29e-06	0.0016	CbGpPWpGaD
Idarubicin—ABCC1—Disease—LDHB—kidney cancer	7.15e-06	0.00157	CbGpPWpGaD
Idarubicin—ABCC1—Disease—SFRP2—kidney cancer	7.15e-06	0.00157	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GPC3—kidney cancer	7.04e-06	0.00154	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	6.99e-06	0.00153	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	6.87e-06	0.00151	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CA2—kidney cancer	6.85e-06	0.0015	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—GSTP1—kidney cancer	6.8e-06	0.00149	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—GSTP1—kidney cancer	6.74e-06	0.00148	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	6.7e-06	0.00147	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ALAD—kidney cancer	6.67e-06	0.00146	CbGpPWpGaD
Idarubicin—ABCC1—Disease—TCEB1—kidney cancer	6.67e-06	0.00146	CbGpPWpGaD
Idarubicin—ABCC1—Disease—TCEB2—kidney cancer	6.67e-06	0.00146	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	6.65e-06	0.00146	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	6.64e-06	0.00145	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ST3GAL2—kidney cancer	6.51e-06	0.00143	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	6.42e-06	0.00141	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ALDH1A1—kidney cancer	6.37e-06	0.0014	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—GSTM1—kidney cancer	6.25e-06	0.00137	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	6.21e-06	0.00136	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—GSTM1—kidney cancer	6.19e-06	0.00136	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	6.16e-06	0.00135	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	6.11e-06	0.00134	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PGK1—kidney cancer	6.1e-06	0.00134	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—SLC5A3—kidney cancer	6.1e-06	0.00134	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—LDHB—kidney cancer	5.99e-06	0.00131	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—TP53—kidney cancer	5.96e-06	0.00131	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	5.92e-06	0.0013	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	5.87e-06	0.00129	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	5.84e-06	0.00128	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	5.79e-06	0.00127	CbGpPWpGaD
Idarubicin—ABCC1—Disease—RPL14—kidney cancer	5.42e-06	0.00119	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—kidney cancer	5.4e-06	0.00118	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—ABCB1—kidney cancer	5.24e-06	0.00115	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ACY1—kidney cancer	5.21e-06	0.00114	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CA9—kidney cancer	5.19e-06	0.00114	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ACY1—kidney cancer	5.16e-06	0.00113	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.07e-06	0.00111	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ITPR2—kidney cancer	4.9e-06	0.00107	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDKN2A—kidney cancer	4.83e-06	0.00106	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDKN1B—kidney cancer	4.79e-06	0.00105	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CCND1—kidney cancer	4.57e-06	0.001	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PDHB—kidney cancer	4.43e-06	0.000971	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—POMC—kidney cancer	4.42e-06	0.000968	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CRABP1—kidney cancer	4.41e-06	0.000967	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.4e-06	0.000965	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PDHB—kidney cancer	4.39e-06	0.000962	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—POMC—kidney cancer	4.38e-06	0.000959	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDKN1B—kidney cancer	4.28e-06	0.000938	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CCBL1—kidney cancer	4.16e-06	0.000913	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CCBL1—kidney cancer	4.13e-06	0.000905	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PSMD7—kidney cancer	4.11e-06	0.0009	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ITPR2—kidney cancer	4.1e-06	0.000899	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CCND1—kidney cancer	4.08e-06	0.000895	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.78e-06	0.000829	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—MAPK3—kidney cancer	3.77e-06	0.000825	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GSTT1—kidney cancer	3.74e-06	0.00082	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ACHE—kidney cancer	3.74e-06	0.00082	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.73e-06	0.000818	CbGpPWpGaD
Idarubicin—ABCC1—Disease—SLC2A1—kidney cancer	3.71e-06	0.000814	CbGpPWpGaD
Idarubicin—ABCC1—Disease—JUNB—kidney cancer	3.69e-06	0.000808	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—MYC—kidney cancer	3.66e-06	0.000802	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GLIPR1—kidney cancer	3.61e-06	0.000791	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PPAT—kidney cancer	3.61e-06	0.000791	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—MAPK1—kidney cancer	3.58e-06	0.000785	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PPAT—kidney cancer	3.58e-06	0.000784	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GLIPR1—kidney cancer	3.58e-06	0.000784	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—SCARB1—kidney cancer	3.54e-06	0.000776	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.53e-06	0.000774	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PTGS1—kidney cancer	3.51e-06	0.000768	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.5e-06	0.000767	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PSMD7—kidney cancer	3.44e-06	0.000753	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MAPK3—kidney cancer	3.37e-06	0.000738	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—APRT—kidney cancer	3.36e-06	0.000736	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—FH—kidney cancer	3.36e-06	0.000736	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—FH—kidney cancer	3.33e-06	0.000729	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—APRT—kidney cancer	3.33e-06	0.000729	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MYC—kidney cancer	3.27e-06	0.000718	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—BCHE—kidney cancer	3.26e-06	0.000714	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.25e-06	0.000713	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—SLC5A5—kidney cancer	3.22e-06	0.000705	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MAPK1—kidney cancer	3.2e-06	0.000702	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GPC3—kidney cancer	3.16e-06	0.000692	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GPC3—kidney cancer	3.13e-06	0.000686	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—SLC2A1—kidney cancer	3.11e-06	0.000681	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CA2—kidney cancer	3.07e-06	0.000673	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CA2—kidney cancer	3.04e-06	0.000667	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.02e-06	0.000661	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CDKN2B—kidney cancer	3e-06	0.000657	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ALAD—kidney cancer	2.99e-06	0.000656	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ALAD—kidney cancer	2.97e-06	0.00065	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.97e-06	0.00065	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ST3GAL2—kidney cancer	2.92e-06	0.00064	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ST3GAL2—kidney cancer	2.9e-06	0.000634	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ALDH1A1—kidney cancer	2.85e-06	0.000625	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ALDH1A1—kidney cancer	2.83e-06	0.00062	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PGK1—kidney cancer	2.74e-06	0.0006	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SLC5A3—kidney cancer	2.74e-06	0.0006	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SLC5A3—kidney cancer	2.71e-06	0.000594	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PGK1—kidney cancer	2.71e-06	0.000594	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—TP53—kidney cancer	2.69e-06	0.000589	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—LDHB—kidney cancer	2.68e-06	0.000588	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—LDHB—kidney cancer	2.66e-06	0.000583	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.63e-06	0.000577	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GSTP1—kidney cancer	2.59e-06	0.000568	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ABCB1—kidney cancer	2.45e-06	0.000538	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HIF1A—kidney cancer	2.4e-06	0.000526	CbGpPWpGaD
Idarubicin—ABCC1—Disease—TSC2—kidney cancer	2.39e-06	0.000524	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GSTM1—kidney cancer	2.38e-06	0.000522	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CA9—kidney cancer	2.33e-06	0.00051	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CA9—kidney cancer	2.31e-06	0.000505	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP1A1—kidney cancer	2.26e-06	0.000495	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.25e-06	0.000494	CbGpPWpGaD
Idarubicin—ABCC1—Disease—APC—kidney cancer	2.11e-06	0.000463	CbGpPWpGaD
Idarubicin—ABCC1—Disease—KIT—kidney cancer	2.11e-06	0.000463	CbGpPWpGaD
Idarubicin—ABCC1—Disease—BRAF—kidney cancer	1.99e-06	0.000435	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CRABP1—kidney cancer	1.98e-06	0.000434	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CRABP1—kidney cancer	1.96e-06	0.00043	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.86e-06	0.000407	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ITPR2—kidney cancer	1.84e-06	0.000403	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ITPR2—kidney cancer	1.82e-06	0.0004	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—POMC—kidney cancer	1.68e-06	0.000369	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.68e-06	0.000368	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTT1—kidney cancer	1.68e-06	0.000368	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ACHE—kidney cancer	1.68e-06	0.000368	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTT1—kidney cancer	1.66e-06	0.000364	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ACHE—kidney cancer	1.66e-06	0.000364	CbGpPWpGaD
Idarubicin—ABCC1—Disease—RAF1—kidney cancer	1.66e-06	0.000363	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ERBB2—kidney cancer	1.64e-06	0.00036	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MTOR—kidney cancer	1.62e-06	0.000355	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CD4—kidney cancer	1.62e-06	0.000354	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PTGS2—kidney cancer	1.6e-06	0.000352	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SCARB1—kidney cancer	1.59e-06	0.000348	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SCARB1—kidney cancer	1.57e-06	0.000345	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PTGS1—kidney cancer	1.57e-06	0.000344	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PTGS1—kidney cancer	1.56e-06	0.000341	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PSMD7—kidney cancer	1.54e-06	0.000338	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PSMD7—kidney cancer	1.53e-06	0.000335	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CDKN1B—kidney cancer	1.52e-06	0.000333	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—BCHE—kidney cancer	1.46e-06	0.00032	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—BCHE—kidney cancer	1.45e-06	0.000317	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.44e-06	0.000316	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CTNNB1—kidney cancer	1.44e-06	0.000315	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.43e-06	0.000314	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PTEN—kidney cancer	1.4e-06	0.000307	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.39e-06	0.000305	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.38e-06	0.000303	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PTGS2—kidney cancer	1.34e-06	0.000294	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.34e-06	0.000294	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MAPK3—kidney cancer	1.2e-06	0.000262	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PTEN—kidney cancer	1.17e-06	0.000257	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.17e-06	0.000256	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MYC—kidney cancer	1.16e-06	0.000255	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTP1—kidney cancer	1.16e-06	0.000255	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTP1—kidney cancer	1.15e-06	0.000253	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MAPK1—kidney cancer	1.14e-06	0.000249	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ABCB1—kidney cancer	1.1e-06	0.000241	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ABCB1—kidney cancer	1.09e-06	0.000239	CbGpPWpGaD
Idarubicin—ABCC1—Disease—KRAS—kidney cancer	1.07e-06	0.000235	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTM1—kidney cancer	1.07e-06	0.000234	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTM1—kidney cancer	1.06e-06	0.000232	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP1A1—kidney cancer	1.01e-06	0.000222	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP1A1—kidney cancer	1e-06	0.00022	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PIK3CA—kidney cancer	9.87e-07	0.000216	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CA—kidney cancer	8.27e-07	0.000181	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.25e-07	0.000181	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—POMC—kidney cancer	7.55e-07	0.000165	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—POMC—kidney cancer	7.49e-07	0.000164	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PTGS2—kidney cancer	6.02e-07	0.000132	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PTGS2—kidney cancer	5.97e-07	0.000131	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PTEN—kidney cancer	5.25e-07	0.000115	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PTEN—kidney cancer	5.21e-07	0.000114	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CA—kidney cancer	3.71e-07	8.12e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CA—kidney cancer	3.67e-07	8.05e-05	CbGpPWpGaD
